ArticleFrontiers in sleep2026
Prevalence of different parasomnias in the general Norwegian population, and their association with insomnia, anxiety, and depression. A cross-sectional web-panel survey.
Article in Frontiers in sleep, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Melatonin in Clinical Practice: Grey Zones Between Chronobiology, Insomnia and Consumer Supplementation.Clocks & sleep · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To estimate the prevalence of various parasomnias in the general Norwegian adult population and explore their associations with insomnia, anxiety, and depression. Methods: A cross-sectional online survey was conducted in September 2024 among 1002 adults (50.7% male, mean age 50.3), drawn from a large population-based sample from a national web panel. Participants reported lifetime and past 3-month (current) prevalence of eleven different parasomnias, including both NREM- and REM-related subtypes. Validated instruments assessed insomnia (Bergen Insomnia Scale), anxiety and depression (Patient Health Questionnaire-4). Associations were analyzed using chi-square tests and logistic regressions, adjusting for age, sex, educational level, and circadian preference. Response rate was 19.8%. Results: Lifetime prevalence of the parasomnias ranged from 2.3% (sleep-related eating disorder) to 47.2% (nightmares), while current prevalence ranged from 1.0% (injured somebody else during sleep) to 33.1% (nightmares). Insomnia, anxiety, and depression were associated with most of the parasomnias [e.g., nightmares-anxiety (OR 1.58; CI 1.42-1.74)]. Parasomnias were more common in younger participants, while sex differences were few. Conclusion: Many of the parasomnias were commonly reported and strongly associated with insomnia and mental health symptoms. These findings underscore the need for increased clinical awareness and further research on parasomnias.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.